SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '63K'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWJ_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	VAL A1092 ALA A1108 LEU A1140 LEU A1195 HIS A1202	63K A1401 (-4.9A) 63K A1401 (-3.5A) None None None	0.52A	1uwjA-5horA: 7.4	1uwjA-5horA: 30.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	10 / 12	VAL A1092 ALA A1108 LEU A1140 LEU A1157 TYR A1159 MET A1160 GLY A1163 MET A1211 ALA A1221 ASP A1222	63K A1401 (-4.9A) 63K A1401 (-3.5A) None 63K A1401 (-4.2A) 63K A1401 (-3.5A) None 63K A1401 (-3.6A) 63K A1401 (-4.0A) 63K A1401 (-3.3A) None	0.43A	2wgjA-5horA: 33.2	2wgjA-5horA: 96.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XP2_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	VAL A1092 ALA A1108 LEU A1157 MET A1160 GLY A1163 ASP A1222	63K A1401 (-4.9A) 63K A1401 (-3.5A) 63K A1401 (-4.2A) None 63K A1401 (-3.6A) None	0.62A	2xp2A-5horA: 13.6	2xp2A-5horA: 33.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_A_NILA600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 GLY A1163 PHE A1200 HIS A1202 ALA A1221	63K A1401 (-3.5A) 63K A1401 (-3.6A) None None 63K A1401 (-3.3A)	0.44A	3cs9A-5horA: 26.7	3cs9A-5horA: 38.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 MET A1131 PHE A1200 HIS A1202 ALA A1221	63K A1401 (-3.5A) None None None 63K A1401 (-3.3A)	0.75A	3cs9C-5horA: 28.9	3cs9C-5horA: 38.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 PHE A1200 HIS A1202 ALA A1221 ASP A1222	63K A1401 (-3.5A) None None 63K A1401 (-3.3A) None	0.91A	3cs9C-5horA: 28.9	3cs9C-5horA: 38.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_D_NILD600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 GLY A1163 PHE A1200 HIS A1202 ALA A1221	63K A1401 (-3.5A) 63K A1401 (-3.6A) None None 63K A1401 (-3.3A)	0.52A	3cs9D-5horA: 26.5	3cs9D-5horA: 38.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_D_NILD600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	MET A1131 GLY A1163 PHE A1200 HIS A1202 ALA A1221	None 63K A1401 (-3.6A) None None 63K A1401 (-3.3A)	0.65A	3cs9D-5horA: 26.5	3cs9D-5horA: 38.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	VAL A1092 ALA A1108 LEU A1140 PHE A1223 GLY A1224	63K A1401 (-4.9A) 63K A1401 (-3.5A) None None None	0.54A	3og7A-5horA: 26.0	3og7A-5horA: 29.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_2 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	3 / 3	LEU A1157 MET A1160 ASP A1164	63K A1401 (-4.2A) None 63K A1401 (-4.0A)	0.50A	3v5wA-5horA: 7.2	3v5wA-5horA: 17.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	ALA A1108 LEU A1140 LEU A1157 MET A1160 GLY A1163 ASP A1164	63K A1401 (-3.5A) None 63K A1401 (-4.2A) None 63K A1401 (-3.6A) 63K A1401 (-4.0A)	0.42A	3zbfA-5horA: 28.0	3zbfA-5horA: 36.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	ALA A1108 LEU A1140 MET A1160 GLY A1163 ASP A1164 ASP A1222	63K A1401 (-3.5A) None None 63K A1401 (-3.6A) 63K A1401 (-4.0A) None	0.50A	3zbfA-5horA: 28.0	3zbfA-5horA: 36.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANQ_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 9	VAL A1092 ALA A1108 LEU A1157 MET A1160 GLY A1163 ALA A1221 ASP A1222	63K A1401 (-4.9A) 63K A1401 (-3.5A) 63K A1401 (-4.2A) None 63K A1401 (-3.6A) 63K A1401 (-3.3A) None	0.62A	4anqA-5horA: 25.7	4anqA-5horA: 32.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANS_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	VAL A1092 ALA A1108 MET A1160 GLY A1163 ALA A1221 ASP A1222	63K A1401 (-4.9A) 63K A1401 (-3.5A) None 63K A1401 (-3.6A) 63K A1401 (-3.3A) None	0.59A	4ansA-5horA: 25.7	4ansA-5horA: 33.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QRC_A_0LIA802_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 MET A1131 LEU A1195 ARG A1203 ALA A1221	63K A1401 (-3.5A) None None None 63K A1401 (-3.3A)	1.05A	4qrcA-5horA: 24.7	4qrcA-5horA: 32.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZV_B_032B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	VAL A1092 ALA A1108 LEU A1140 PHE A1223 GLY A1224	63K A1401 (-4.9A) 63K A1401 (-3.5A) None None None	0.63A	4rzvB-5horA: 25.9	4rzvB-5horA: 29.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U5J_B_RXTB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	VAL A1092 ALA A1108 TYR A1159 MET A1160 GLY A1163 ASP A1222	63K A1401 (-4.9A) 63K A1401 (-3.5A) 63K A1401 (-3.5A) None 63K A1401 (-3.6A) None	0.58A	4u5jB-5horA: 9.1	4u5jB-5horA: 36.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 MET A1131 LEU A1195 HIS A1202 ALA A1221	63K A1401 (-3.5A) None None None 63K A1401 (-3.3A)	0.61A	4v01A-5horA: 27.3	4v01A-5horA: 35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 MET A1131 LEU A1195 HIS A1202 ALA A1221	63K A1401 (-3.5A) None None None 63K A1401 (-3.3A)	0.60A	4v01B-5horA: 27.1	4v01B-5horA: 35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 12	VAL A1092 ALA A1108 LEU A1195 HIS A1202 ALA A1221 GLY A1224	63K A1401 (-4.9A) 63K A1401 (-3.5A) None None 63K A1401 (-3.3A) None	0.83A	4v04A-5horA: 26.0	4v04A-5horA: 35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 LEU A1195 HIS A1202 ALA A1221 GLY A1224	63K A1401 (-3.5A) None None 63K A1401 (-3.3A) None	0.89A	4v04B-5horA: 26.5	4v04B-5horA: 35.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WA9_A_AXIA9000_1 (TYROSINE-PROTEIN KINASE ABL1)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 11	ALA A1108 LYS A1110 MET A1160 GLY A1163 ASN A1209 ALA A1221	63K A1401 (-3.5A) None None 63K A1401 (-3.6A) None 63K A1401 (-3.3A)	0.84A	4wa9A-5horA: 22.9	4wa9A-5horA: 37.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAA_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	6 / 9	VAL A1092 ALA A1108 LEU A1157 MET A1160 GLY A1163 ASP A1222	63K A1401 (-4.9A) 63K A1401 (-3.5A) 63K A1401 (-4.2A) None 63K A1401 (-3.6A) None	0.63A	5aaaA-5horA: 24.8	5aaaA-5horA: 33.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAC_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	7 / 10	VAL A1092 ALA A1108 LYS A1110 LEU A1157 MET A1160 GLY A1163 ASP A1222	63K A1401 (-4.9A) 63K A1401 (-3.5A) None 63K A1401 (-4.2A) None 63K A1401 (-3.6A) None	0.71A	5aacA-5horA: 28.3	5aacA-5horA: 33.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HES_A_032A401_1 (MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	VAL A1092 ALA A1108 TYR A1159 PHE A1223 GLY A1224	63K A1401 (-4.9A) 63K A1401 (-3.5A) 63K A1401 (-3.5A) None None	0.69A	5hesA-5horA: 11.1	5hesA-5horA: 28.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_2 (TYROSINE-PROTEIN KINASE ABL1)	5hor	HEPATOCYTE GROWTH FACTOR RECEPTOR (Homo sapiens)	5 / 12	ALA A1108 MET A1131 PHE A1200 HIS A1202 ALA A1221	63K A1401 (-3.5A) None None None 63K A1401 (-3.3A)	0.72A	5mo4A-5horA: 5.6	5mo4A-5horA: 27.52

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1UWJ_A_BAXA1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"VAL A1092;ALA A1108;LEU A1140;LEU A1195;HIS A1202","63K A1401 (-4.9A);63K A1401 (-3.5A);None;None;None","0.52A","1uwjA-5horA:7.4",null],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",10,"VAL A1092;ALA A1108;LEU A1140;LEU A1157;TYR A1159;MET A1160;GLY A1163;MET A1211;ALA A1221;ASP A1222","63K A1401 (-4.9A);63K A1401 (-3.5A);None;63K A1401 (-4.2A);63K A1401 (-3.5A);None;63K A1401 (-3.6A);63K A1401 (-4.0A);63K A1401 (-3.3A);None","0.43A","2wgjA-5horA:33.2","1uwjA-5horA:30.45"],["2XP2_A_VGHA9000_1","TYROSINE-PROTEIN KINASE RECEPTOR","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;LEU A1157;MET A1160;GLY A1163;ASP A1222","63K A1401 (-4.9A);63K A1401 (-3.5A);63K A1401 (-4.2A);None;63K A1401 (-3.6A);None","0.62A","2xp2A-5horA:13.6","2wgjA-5horA:96.09"],["3CS9_A_NILA600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;GLY A1163;PHE A1200;HIS A1202;ALA A1221","63K A1401 (-3.5A);63K A1401 (-3.6A);None;None;63K A1401 (-3.3A)","0.44A","3cs9A-5horA:26.7","2xp2A-5horA:33.04"],["3CS9_C_NILC600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;MET A1131;PHE A1200;HIS A1202;ALA A1221","63K A1401 (-3.5A);None;None;None;63K A1401 (-3.3A)","0.75A","3cs9C-5horA:28.9","3cs9A-5horA:38.89"],["3CS9_C_NILC600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;PHE A1200;HIS A1202;ALA A1221;ASP A1222","63K A1401 (-3.5A);None;None;63K A1401 (-3.3A);None","0.91A","3cs9C-5horA:28.9","3cs9C-5horA:38.89"],["3CS9_D_NILD600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;GLY A1163;PHE A1200;HIS A1202;ALA A1221","63K A1401 (-3.5A);63K A1401 (-3.6A);None;None;63K A1401 (-3.3A)","0.52A","3cs9D-5horA:26.5","3cs9C-5horA:38.89"],["3CS9_D_NILD600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"MET A1131;GLY A1163;PHE A1200;HIS A1202;ALA A1221","None;63K A1401 (-3.6A);None;None;63K A1401 (-3.3A)","0.65A","3cs9D-5horA:26.5","3cs9D-5horA:38.89"],["3OG7_A_032A1_1","AKAP9-BRAF FUSION PROTEIN","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"VAL A1092;ALA A1108;LEU A1140;PHE A1223;GLY A1224","63K A1401 (-4.9A);63K A1401 (-3.5A);None;None;None","0.54A","3og7A-5horA:26.0","3cs9D-5horA:38.89"],["3V5W_A_8PRA701_2","G-PROTEIN COUPLED RECEPTOR KINASE 2","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",3,"LEU A1157;MET A1160;ASP A1164","63K A1401 (-4.2A);None;63K A1401 (-4.0A)","0.50A","3v5wA-5horA:7.2","3og7A-5horA:29.75"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A1108;LEU A1140;LEU A1157;MET A1160;GLY A1163;ASP A1164","63K A1401 (-3.5A);None;63K A1401 (-4.2A);None;63K A1401 (-3.6A);63K A1401 (-4.0A)","0.42A","3zbfA-5horA:28.0","3v5wA-5horA:17.39"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A1108;LEU A1140;MET A1160;GLY A1163;ASP A1164;ASP A1222","63K A1401 (-3.5A);None;None;63K A1401 (-3.6A);63K A1401 (-4.0A);None","0.50A","3zbfA-5horA:28.0","3zbfA-5horA:36.25"],["4ANQ_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A1092;ALA A1108;LEU A1157;MET A1160;GLY A1163;ALA A1221;ASP A1222","63K A1401 (-4.9A);63K A1401 (-3.5A);63K A1401 (-4.2A);None;63K A1401 (-3.6A);63K A1401 (-3.3A);None","0.62A","4anqA-5horA:25.7","3zbfA-5horA:36.25"],["4ANS_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;MET A1160;GLY A1163;ALA A1221;ASP A1222","63K A1401 (-4.9A);63K A1401 (-3.5A);None;63K A1401 (-3.6A);63K A1401 (-3.3A);None","0.59A","4ansA-5horA:25.7","4anqA-5horA:32.95"],["4QRC_A_0LIA802_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;MET A1131;LEU A1195;ARG A1203;ALA A1221","63K A1401 (-3.5A);None;None;None;63K A1401 (-3.3A)","1.05A","4qrcA-5horA:24.7","4ansA-5horA:33.14"],["4RZV_B_032B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"VAL A1092;ALA A1108;LEU A1140;PHE A1223;GLY A1224","63K A1401 (-4.9A);63K A1401 (-3.5A);None;None;None","0.63A","4rzvB-5horA:25.9","4qrcA-5horA:32.95"],["4U5J_B_RXTB601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;TYR A1159;MET A1160;GLY A1163;ASP A1222","63K A1401 (-4.9A);63K A1401 (-3.5A);63K A1401 (-3.5A);None;63K A1401 (-3.6A);None","0.58A","4u5jB-5horA:9.1","4rzvB-5horA:29.85"],["4V01_A_0LIA1776_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;MET A1131;LEU A1195;HIS A1202;ALA A1221","63K A1401 (-3.5A);None;None;None;63K A1401 (-3.3A)","0.61A","4v01A-5horA:27.3","4u5jB-5horA:36.76"],["4V01_B_0LIB1770_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;MET A1131;LEU A1195;HIS A1202;ALA A1221","63K A1401 (-3.5A);None;None;None;63K A1401 (-3.3A)","0.60A","4v01B-5horA:27.1","4v01A-5horA:35.22"],["4V04_A_0LIA1772_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;LEU A1195;HIS A1202;ALA A1221;GLY A1224","63K A1401 (-4.9A);63K A1401 (-3.5A);None;None;63K A1401 (-3.3A);None","0.83A","4v04A-5horA:26.0","4v01B-5horA:35.22"],["4V04_B_0LIB1771_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;LEU A1195;HIS A1202;ALA A1221;GLY A1224","63K A1401 (-3.5A);None;None;63K A1401 (-3.3A);None","0.89A","4v04B-5horA:26.5","4v04A-5horA:35.22"],["4WA9_A_AXIA9000_1","TYROSINE-PROTEIN KINASE ABL1","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"ALA A1108;LYS A1110;MET A1160;GLY A1163;ASN A1209;ALA A1221","63K A1401 (-3.5A);None;None;63K A1401 (-3.6A);None;63K A1401 (-3.3A)","0.84A","4wa9A-5horA:22.9","4v04B-5horA:35.22"],["5AAA_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",6,"VAL A1092;ALA A1108;LEU A1157;MET A1160;GLY A1163;ASP A1222","63K A1401 (-4.9A);63K A1401 (-3.5A);63K A1401 (-4.2A);None;63K A1401 (-3.6A);None","0.63A","5aaaA-5horA:24.8","4wa9A-5horA:37.42"],["5AAC_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",7,"VAL A1092;ALA A1108;LYS A1110;LEU A1157;MET A1160;GLY A1163;ASP A1222","63K A1401 (-4.9A);63K A1401 (-3.5A);None;63K A1401 (-4.2A);None;63K A1401 (-3.6A);None","0.71A","5aacA-5horA:28.3","5aaaA-5horA:33.04"],["5HES_A_032A401_1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"VAL A1092;ALA A1108;TYR A1159;PHE A1223;GLY A1224","63K A1401 (-4.9A);63K A1401 (-3.5A);63K A1401 (-3.5A);None;None","0.69A","5hesA-5horA:11.1","5aacA-5horA:33.04"],["5MO4_A_NILA601_2","TYROSINE-PROTEIN KINASE ABL1","5hor","HEPATOCYTE GROWTH FACTOR RECEPTOR","Homo sapiens",5,"ALA A1108;MET A1131;PHE A1200;HIS A1202;ALA A1221","63K A1401 (-3.5A);None;None;None;63K A1401 (-3.3A)","0.72A","5mo4A-5horA:5.6","5hesA-5horA:28.70"]]